-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

Benzinga·10/16/2026 11:36:56
Listen to the news
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.